0000929638-23-002985.txt : 20231102 0000929638-23-002985.hdr.sgml : 20231102 20231102160530 ACCESSION NUMBER: 0000929638-23-002985 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231102 DATE AS OF CHANGE: 20231102 EFFECTIVENESS DATE: 20231102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ayala Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001100397 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841521955 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-496373 FILM NUMBER: 231372189 BUSINESS ADDRESS: STREET 1: 9 DEER PARK DRIVE STREET 2: SUITE K-1 CITY: MONMOUTH JUNCTION STATE: NJ ZIP: 08852 BUSINESS PHONE: 732 545 1590 MAIL ADDRESS: STREET 1: 9 DEER PARK DRIVE STREET 2: SUITE K-1 CITY: MONMOUTH JUNCTION STATE: NJ ZIP: 08852 FORMER COMPANY: FORMER CONFORMED NAME: Advaxis, Inc. DATE OF NAME CHANGE: 20050105 FORMER COMPANY: FORMER CONFORMED NAME: GREAT EXPECTATIONS & ASSOCIATES INC DATE OF NAME CHANGE: 19991203 D 1 primary_doc.xml X0708 D LIVE 0001100397 Ayala Pharmaceuticals, Inc. 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 732 545 1590 DELAWARE None Advaxis, Inc. GREAT EXPECTATIONS & ASSOCIATES INC Corporation true Ken A. Berlin 9 Deer Park Drive, Suite K-1 Monmouth Junction NJ NEW JERSEY 08852 Director Executive Officer President, Chief Executive Officer and Director Roy Golan 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Executive Officer Chief Financial Officer Igor Gitelman 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Executive Officer SVP Finance and former Interim CFO Andres Gutierrez 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Executive Officer EVP and Chief Medical Officer David Sidransky 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Director Chair of Board Roni A. Appel 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Director Vered Bisker-Leib 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Director Yuval Cabilly 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Director Murray A. Goldberg 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Director Bridget Martell 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Director Pini Orbach 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Director Robert Spiegel 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ NEW JERSEY 08852 Director Biotechnology Decline to Disclose 06b false 2023-10-18 false true true true Shares of common stock true Issuer completed merger where each outstanding target share was exchanged for 1.82285 Issuer common shares. Of shares issued, 466,479 were issued under 506(b) & the remainder under Reg S. 0 433825 433825 0 Amounts above based on $0.93 per share, the closing price of the common stock on OTCQX on date of merger. false 3 0 0 0 Ayala Pharmaceuticals, Inc. /s/ Ken A. Berlin Ken A. Berlin President and CEO 2023-11-02